Cargando…

Computational discovery and experimental validation of novel drug targets in immuno-oncology

Detalles Bibliográficos
Autores principales: Levy, Ofer, Machelnkin, Arthur, Rotman, Galit, Toporik, Amir, Cojocaro, Gady, Dassa, Liat, Vaknin, Ilan, Liang, Spencer, Hunter, John, Neria, Eyal, Levin, Zurit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649332/
http://dx.doi.org/10.1186/2051-1426-3-S2-P184
_version_ 1782401335137665024
author Levy, Ofer
Machelnkin, Arthur
Rotman, Galit
Toporik, Amir
Cojocaro, Gady
Dassa, Liat
Vaknin, Ilan
Liang, Spencer
Hunter, John
Neria, Eyal
Levin, Zurit
author_facet Levy, Ofer
Machelnkin, Arthur
Rotman, Galit
Toporik, Amir
Cojocaro, Gady
Dassa, Liat
Vaknin, Ilan
Liang, Spencer
Hunter, John
Neria, Eyal
Levin, Zurit
author_sort Levy, Ofer
collection PubMed
description
format Online
Article
Text
id pubmed-4649332
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46493322015-11-24 Computational discovery and experimental validation of novel drug targets in immuno-oncology Levy, Ofer Machelnkin, Arthur Rotman, Galit Toporik, Amir Cojocaro, Gady Dassa, Liat Vaknin, Ilan Liang, Spencer Hunter, John Neria, Eyal Levin, Zurit J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649332/ http://dx.doi.org/10.1186/2051-1426-3-S2-P184 Text en Copyright © 2015 Levy et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Levy, Ofer
Machelnkin, Arthur
Rotman, Galit
Toporik, Amir
Cojocaro, Gady
Dassa, Liat
Vaknin, Ilan
Liang, Spencer
Hunter, John
Neria, Eyal
Levin, Zurit
Computational discovery and experimental validation of novel drug targets in immuno-oncology
title Computational discovery and experimental validation of novel drug targets in immuno-oncology
title_full Computational discovery and experimental validation of novel drug targets in immuno-oncology
title_fullStr Computational discovery and experimental validation of novel drug targets in immuno-oncology
title_full_unstemmed Computational discovery and experimental validation of novel drug targets in immuno-oncology
title_short Computational discovery and experimental validation of novel drug targets in immuno-oncology
title_sort computational discovery and experimental validation of novel drug targets in immuno-oncology
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649332/
http://dx.doi.org/10.1186/2051-1426-3-S2-P184
work_keys_str_mv AT levyofer computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT machelnkinarthur computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT rotmangalit computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT toporikamir computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT cojocarogady computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT dassaliat computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT vakninilan computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT liangspencer computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT hunterjohn computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT neriaeyal computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology
AT levinzurit computationaldiscoveryandexperimentalvalidationofnoveldrugtargetsinimmunooncology